Rho Kinases and Ischemic Cerebrovascular Diseases
Abstract: Rho kinases (Rho associated kinases, ROCK) are involved in various signaling pathways in the pathogenesis of cerebral ischemia. The article outlines the role of ROCK in ischemic cerebrovascular diseases, which provides theoretical reference for ischemic cerebrovascular diseases.
文章引用: 林辰雨 , 汪 宁 (2014) Rho激酶与缺血性脑血管疾病。 药物资讯， 3， 19-21. doi: 10.12677/PI.2014.31005
 Hall, A. (1998) Rho GTPases and the actin cytoskeleton. Science, 279, 509-514.
 Nakamura, F. (2013) FilGAP and its close relatives: A mediator of Rho-Rac antagonism that regulates cell morphology and migration. Biochemical Journal, 453, 17-25.
 Doran, J.D., Liu, X., Taslimi, P., et al. (2004) New insights into the structure function relationships of Rho associated kinase: A thermodynamic and hydrodynamic study of the dimer to monomer transition and its kinetic implications. Biochemical Journal, 384, 255-262.
 Catharine, A. and Bryan, B.A. (2011) Rho kinase proteins— Pleiotropic modulators of cell survival and apoptosis. Anticancer Research, 31, 3645-3657.
 Naraoka, M., Munakata, A., Matsuda, N., Shimamura, N. and Ohkuma, H. (2013) Suppression of the Rho/Rho-Kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit. Translational Stroke Research, 4, 368-374.
 Heasman, S.J. and Ridley, A.J. (2008) Mammalian Rho GTPases: New insights into their functions from in vivo studies. Nature Reviews Molecular Cell Biology, 9, 690-701.
 Diebold, B.A., Fowler, B., Lu, J., et al. (2004) Antagonistic cross talk between Rac and Cdc42 GTPases regulates generation of reactive oxygen species. The Journal of Biological Chemistry, 279, 28136-28142.
 Sahai, E. and Marshall, C.J. (2002) Rho-GTPases and cancer. Nature Reviews Cancer, 2, 133-142.
 Van Aelst, L. and D’Souza-Schorey, C. (1997) Rho GTPases and signalling networks. Genes & Development, 11, 2295-2322.
 Takemoto, M., Sun, J., Hiroki, J., Shimokawa, H. and Liao, J.K. (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation, 106, 57-62.
 Joshi, A.D., Dimitropoulou, C., Thangjam, G., Snead, C. and Feldman, S. (2013) Hsp90 inhibitors prevent LPS-induced endothelial barrier dysfunction by disrupting RhoA signaling. American Journal of Respiratory Cell and Molecular Biology, 23, 4553.
 Lees, K.R., Diener, H.C., Asplund, K., et al. (2003) UK 279, 276, a neutrophil inhibitory glycoprotein, in acute stroke: Tolerability and pharmacokinetics. Stroke, 34, 1704-1709.
 Shi, J. and Wei, L. (2007) Rho kinase in the regulation of cell death and survival. Archivum Immunologiae et Therapia Experimentalis, 55, 61-75.
 Shin, H.K., Salomone, S., Potts, E.M., et al. (2007) Rhokinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. Journal of Cerebral Blood Flow & Metabolism, 27, 998-1009.
 Shibuya, M., Hirai, S., Seto, M., et al. (2005) Effects of fasudil in acute ischemic stroke: Results of a prospective placebo controlled double blind trial. Journal of the Neurological Sciences, 15, 31-39.
 Wang, S., Lee, S.R., Guo, S.Z., et al. (2006) Reduction of tissue plasminogen activator induced matrix metalloproteinase9 by simvastatin in astrocytes. Stroke, 37, 1910-1912.
 Rikitake, Y., Kim, H.H., Huang, Z., et al. (2005) Inhibition of Rhokinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke, 36, 2251-2257.
 刘康, 丁素菊, 吴涛, 等 (2011) Rho激酶抑制剂对大鼠脑缺血损伤的脑保护作用及S100B蛋白表达的影响. 临床神经病学杂志, 2, 111-113.